Brian A. King appointed as new CTP director by FDA

May.23.2022
Dr. Brian A.King is appointed as the new director of the Center for Tobacco Products by the FDA.

The United States Food and Drug Administration (FDA) has appointed Brian A. King as the new director of the Center for Tobacco Products (CTP).

 

After an intensive executive search, I have chosen Dr. Brian A. King to serve as the new director for the FDA's Center for Tobacco Products," wrote Robert Califf on Twitter. "Dr. King brings impressive expertise in tobacco prevention and control, and has over 10 years of experience working at the CDC, making him well-versed in the operations of the FDA.

 

King is the Deputy Director of Research Translation at the Smoking and Health Office (OSH) of the National Center for Chronic Disease Prevention and Health Promotion at the Centers for Disease Control and Prevention (CDC). In this role, he is responsible for providing scientific leadership and technical expertise to the federal lead agency CDC/OSH for comprehensive tobacco prevention and control efforts.

 

In 2010, King joined the Centers for Disease Control and Prevention as an Epidemic Intelligence Service officer. Prior to this, he worked at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, as a research affiliate in cancer prevention and population sciences division. During his time at Roswell Park, his main research focused on tobacco prevention and control.

 

For the past 15 years, King has been dedicated to providing reliable scientific evidence to inform tobacco control policies, effectively communicating this information to key stakeholders including decision makers, media, and the general public. He has authored or co-authored over 200 peer-reviewed scientific articles on tobacco prevention and control, was the author of the Surgeon General's 50th anniversary report on smoking and health, and was the lead author for the Centers for Disease Control and Prevention's 2014 update to the evidence-based national guidelines for comprehensive tobacco control programs. King also served as a senior editor for the 2016 Surgeon General's report on youth and young adult e-cigarette use and the 2020 Surgeon General's report on quitting smoking. He was also a senior official for the CDC's emergency response to the 2019 outbreak of lung injury associated with e-cigarette or vaping product use.

 

King holds a Doctorate in Epidemiology and a Master's Degree in Public Health from the State University of New York at Buffalo.

 

Source: Tobacco Reporter.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

California Bill Would Let Schools Include Nicotine in Student-Athlete Drug Screens
California Bill Would Let Schools Include Nicotine in Student-Athlete Drug Screens
California lawmakers are advancing a bill that would allow schools with existing student-athlete drug testing programs to include nicotine in those screenings.
Apr.09 by 2FIRSTS.ai
BAT FY2025 Results: New Categories Contribution Expands as Smokeless Share Reaches 18.2%
BAT FY2025 Results: New Categories Contribution Expands as Smokeless Share Reaches 18.2%
British American Tobacco reported FY2025 revenue of £25.61 billion, down 1.0% on a reported basis but up 2.1% at constant currency. New Categories revenue rose 5.5%, with category contribution increasing 77%. Smokeless products accounted for 18.2% of group revenue.
Feb.12
York Traders Could Face Fines of Up to GBP 200 Under New Illegal Vape Enforcement Plans
York Traders Could Face Fines of Up to GBP 200 Under New Illegal Vape Enforcement Plans
City of York Council is considering new plans that would allow fines of up to GBP 200.00 (approximately USD 260.00) for traders caught selling illegal single-use vapes.
Apr.09 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Cyprus Bill to Regulate Nicotine Pouches Expected to Reach House Plenary in Early April
Cyprus Bill to Regulate Nicotine Pouches Expected to Reach House Plenary in Early April
A proposed law to regulate nicotine pouches in Cyprus is expected to reach the House plenary session in early April. The bill, submitted by Diko MP Chrysis Pantelidis, aims to establish a regulatory framework governing the marketing, composition and quality of nicotine pouches currently circulating on the market and to incorporate them into existing smoking control legislation.
Mar.13 by 2FIRSTS.ai
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai